Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experience

ATALAR B., Ozsahin M., Call J., Napieralska A., Kamer S., Villa S., ...More

RADIOTHERAPY AND ONCOLOGY, vol.127, no.1, pp.96-102, 2018 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 127 Issue: 1
  • Publication Date: 2018
  • Doi Number: 10.1016/j.radonc.2017.12.028
  • Journal Name: RADIOTHERAPY AND ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.96-102
  • Keywords: Adult medulloblastoma, Chemotherapy, Craniospinal, Multimodality, Radiotherapy, Rare Cancer Network (RCN), NONMETASTATIC MEDULLOBLASTOMA, ADJUVANT CHEMOTHERAPY, RISK MEDULLOBLASTOMA, SURVIVAL, MULTICENTER, RECURRENCE, STRATEGY
  • Gazi University Affiliated: Yes

Abstract

Background and purpose: The optimal treatment for adults with newly diagnosed medulloblastoma (MB) has not been defined. We report a large series of cases from the Rare Cancer Network.